Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Documentation

  • Home >
  • Investors & media >
  • Documentation
08 April 2021
General meetings

Proxy card – 2021 General Meeting Open in new window

08 April 2021
General meetings

Notice of General Meeting on April 29, 2021 Open in new window

08 April 2021
General meetings

BALO prior notification – 2021 General Meeting Open in new window

08 April 2021
Financial statements and reports, General meetings

2020 Universal Registration Document Open in new window

22 October 2020
Regulated information

Securities Note Open in new window

22 October 2020
Financial statements and reports, Regulated information

Amendment to the 2019 Universal Registration Document Open in new window

30 July 2020
Financial statements and reports

2020 Half-Year Financial Report Open in new window

30 April 2020
General meetings

Compensation policy of the Board members Open in new window

30 April 2020
General meetings

Compensation policy of the Chief Executive Officer and / or any other Corporate Officer Open in new window

30 April 2020
General meetings

Compensation policy of the Chairman of the Board of Directors Open in new window

  • View previous 9 articles
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 14
  • View next 9 articles
© 2023 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page